Transforming growth factor β in breast cancer: another new trick for the old dog
- PMID: 33280167
- DOI: 10.1111/imcb.12421
Transforming growth factor β in breast cancer: another new trick for the old dog
Abstract
Two recent papers from the laboratory of Professor Ming Li demonstrate that inhibition of transforming growth factor β specifically in CD4+ T cells can suppress tumor growth through an unanticipated mechanism.
© 2020 Australian and New Zealand Society for Immunology Inc.
Comment on
-
TGF-β suppresses type 2 immunity to cancer.Nature. 2020 Nov;587(7832):115-120. doi: 10.1038/s41586-020-2836-1. Epub 2020 Oct 21. Nature. 2020. PMID: 33087928 Free PMC article.
-
Cancer immunotherapy via targeted TGF-β signalling blockade in TH cells.Nature. 2020 Nov;587(7832):121-125. doi: 10.1038/s41586-020-2850-3. Epub 2020 Oct 21. Nature. 2020. PMID: 33087933 Free PMC article.
References
REFERENCES
-
- Roberts AB, Anzano MA, Lamb LC, et al. Isolation from murine sarcoma cells of novel transforming growth factors potentiated by EGF. Nature 1982; 295: 417-419.
-
- Connolly EC, Freimuth J, Akhurst RJ. Complexities of TGF-β targeted cancer therapy. Int J Biol Sci 2012; 8: 964-978.
-
- Groeneveldt C, van Hall T, van der Burg SH, Ten Dijke P, van Montfoort N. Immunotherapeutic potential of TGF-β inhibition and oncolytic viruses. Trends Immunol 2020; 41: 406-420.
-
- Derynck R, Turley SJ, Akhurst RJ. TGFβ biology in cancer progression and immunotherapy. Nat Rev Clin Oncol 2021; 18: 9-34.
-
- Liu M, Kuo F, Capistrano KJ, et al. TGF-β suppresses type 2 immunity to cancer. Nature 2020; 587 (7832): 115-120.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials